The UMD-DMD France mutations database
Record ID: 1452

Mutation description


Variation name (cDNA level)Variation name (protein level)Variation statusVariation class
c.4898_4899delAGp.Glu1633GlyfsX19HemizygousMutation

wt codonwt aamutant codonmutant aamutational eventmutation type
GAGGludel2bFs.Stop at 1651Fr.

StructureKey Residue (HCD)Pyrimidin doubletCpG
CRD-repeat #12 

Mutation impact


At the mRNA levelOn restriction map
r.4898_4899delNew restriction site(s): none
Lost restriction site(s): none

On isoforms (a blue cell indicates that the corresponding isoform is affected by the mutation)
Dp 427cDp 427mDp 427pDp 260Dp 140Dp 116Dp 71
       
Immunofluorescence
dys 1 dys 2 dys 3
 No signal with Revertant fibers No signal with Revertant fibers No signal with Revertant fibers
Western Blot
dys 1 dys 2 dys 3
   

Patient and sample data


Sample IDPatient statusGenderTransmissionAge of onsetAge of deathGeographic origin
---215-2-01ProbandMaleDe novoFRANCE

Phenotypic group
 DMD

Reference


Reference IDPubMed IDReference
10015351422
Tuffery-Giraud S, Saquet C, Chambert S, Echenne B, Marie Cuisset J, Rivier F, Cossee M, Philippe C, Monnier N, Bieth E, Recan D, Antoinette Voelckel M, Perelman S, Lambert JC, Malcolm S, Claustres M. The role of muscle biopsy in analysis of the dystrophin gene in Duchenne muscular dystrophy: experience of a national referral centre. Neuromuscul Disord. 2004, 14(10):650-8.